Skip to main content
All lobbying filings

NOVAVAX, INC

Lobbying for NOVAVAX, INC

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate · $230,000.00 expenses · posted Oct 20, 2025

Official filing document

 Lobbying activity 1
Health Issues

Issues related to COVID-19 vaccines, federal vaccine programs, and vaccine regulatory frameworks

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem